cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Agus Prima
Contact Email
chairman@jsocmed.org
Phone
+6281269200232
Journal Mail Official
chairman@jsocmed.org
Editorial Address
Jl. DR. Wahidin Sudiro Husodo No.243B, Kembangan, Klangonan, Kec. Kebomas, Kabupaten Gresik, Jawa Timur 61124
Location
Kab. gresik,
Jawa timur
INDONESIA
The Journal of Society Medicine (JSOCMED)
Published by PT. CoinReads Media Prima
ISSN : -     EISSN : 29645565     DOI : https://doi.org/10.47353/jsocmed.v2i1
Core Subject : Health, Science,
Health Professions Immunology & microbiology Medicine & Pharmacology Neuroscience
The Journal of Society Medicine (JSOCMED) | ISSN (e): 2964-5565 is a leading voice in the Indonesia and internationally for medicine and healthcare. Published continuously, JSOCMED features scholarly comment and clinical research. JSOCMED is editorially independent from and its The Editor-in-Chief (EIC) is Prof. dr. Aznan Lelo, PhD, SpFK. JSOCMED offers many attractive features for authors, including free online access to all research articles, online publication ahead of print, and online responses to articles published as Quick Comments. In addition, as befitting a publication of the Journal of Society Medicine, JSOCMED implements best practice in scientific publishing with an open peer review process, declarations of competing interests and funding, full requirements for patient consent and ethical review, and statements of guarantorship, contributorship, and provenance.
Arjuna Subject : Kedokteran - Kedokteran (Lain-Lain)
Articles 5 Documents
 1 
Search results for , issue "Vol. 2 No. 12 (2023): December" : 5 Documents clear
Current Pathogenesis and Treatment of Cutaneous Lupus Erythematosus Hazlianda, Cut Putri; Diamanda, Ika
Journal of Society Medicine Vol. 2 No. 12 (2023): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v2i12.107

Abstract

Lupus erythematosus (LE) is a chronic autoimmune illness with a broad range of clinical symptoms. These conditions can range from systemic lupus erythematosus (SLE), which affects different organ systems in the body, to cutaneous lupus erythematosus (CLE), which affects only the skin. The precise pathophysiology of CLE is unknown, although it appears to include a complicated interaction of genetic predisposition and environmental stimuli such as UV light, medications, trauma, and hormones. The emergence of the inflammatory infiltrate seen in CLE lesions has also been documented in several studies; this information is crucial for figuring out which specific inflammatory mediators are responsible for tissue damage. Currently prescribed medications for CLE often include antimalarials, systemic corticosteroids, immunosuppressants, and immunomodulators; cytotoxic drugs are only used in the most severe instances.
A Case Series of Bleeding Complication Post Percutaneous Dilatational Tracheostomy and Management Lubis, Batian; Purwaamidjaja, Dis Bima P; Lestari, Mayang Indah; Faisal; Thamrin, Muhammad Husni; Belinda, Febri Akhmad
Journal of Society Medicine Vol. 2 No. 12 (2023): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v2i12.108

Abstract

Introduction: Percutaneous Dilatational Tracheotomy (PDT) is a procedure established for the management of airway and ventilation in the medium to long term for critically ill patients in the ICU. Bleeding is one of the most frequent early complications of tracheostomy. The comorbid conditions of critically ill patients increase the risk of bleeding complications. The aim of this case was to identify factors that increase the risk of bleeding complications in critically ill patients undergoing Percutaneous Dilatational Tracheostomy (PDT) and its management Case: Two cases of patients experiencing bleeding complications after PDT were reported. The bleeding in these patients were suspected to be caused by coagulation disorders due to sepsis and chronic kidney disease. The bleeding occurred on day-1 and 2 post-PDT procedure. Bleeding complications that were not resolved with general management were managed by subcutaneous suturing in the anatomical region of branching arteries and veins that supply the trachea. Conclusion: Bleeding after PDT are a part of early complications of tracheostomy procedures. This complication is more often found in critically ill patients. Management can be carried out by suturing the anatomical region of branching arteries and veins supplying the trachea.
Generalized Exfoliative Dermatitis Suspected Caused by COVID-19 Vaccine : A Case Report Hazlianda, Cut Putri; Dalimunthe, Dina Arwina; Astarina, Awalia
Journal of Society Medicine Vol. 2 No. 12 (2023): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v2i12.109

Abstract

Introduction: Exfoliative dermatitis (ED) is a skin disorder characterized by the presence of erythema and scaling of the skin involving more than 90% of the total body surface area. One of the main etiologic factor of ED is drug hypersensitivity reaction. Vaccine administration can result in allergic reactions. The aim of this case report is to provide information on one of the forms of allergy to the COVID-19 vaccine, which can be ED. Case: A woman, 61 years old, with complaints of reddish patches accompanied by thickened scales and spread throughout the body accompanied by itching, pain in the skin, experiencing fatigue and chills since 3 days ago before the patient said she had received COVID-19 booster vaccine. The patient was diagnosed with generalised exfoliative dermatitis suspected to be caused by the COVID-19 vaccine. The patient was given therapy with oral methylprednisolone 36 mg/day with tapering if there was improvement, and topical urea 10% cream and hydrocortisone 2.5 % cream (face) and desoxymethasone 0.25 % cream (body). Discussion: ED is more common in men than women, with the highest incidence at the age of 40-60 years. The underlying therapy of ED is to address the aetiology and potential complications. The therapy was corticosteroids at a dose of 1-2 mg/kg/day with tapering, emollients and topical corticosteroids. The patient was given these therapies, showed clinical improvement within 5 weeks of treatment and no side effects. Conclusion: Exfoliative dermatitis can be idiopathic or secondary to drug hypersensitivity including vaccine administration. A complete history including history of drug administration and a thorough physical examination are required so that treatment can be given appropriately.
Estimated Glomerular Filtration Rate (eGFR) as a Predictor of 1-Month Clinical Outcome in First-Ever Acute Ischemic Stroke Patients Billi; Akbar, Muhammad; David Gunawan Umbas; Hamid, Firdaus; Bintang, Andi Kurnia; Lotisna, Mimi
Journal of Society Medicine Vol. 2 No. 12 (2023): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v2i12.110

Abstract

Introduction: Renal dysfunction is a new risk factor that is thought to influence the clinical outcome of acute ischemic stroke. In this case, the estimated glomerular filtration rate (eGFR) value is used as an approach to assess kidney function status in acute ischemic stroke patients. This study aims to find the relationship between eGFR and clinical outcomes of acute ischemic stroke. Method: 70 samples were obtained according to inclusion criteria. eGFR is calculated within first week of stroke onset using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula. A normality test was carried out on the data, then determined the correlation and compared eGFR with good [modified Rankin Scale (mRS) 0-2] and poor (mRS 3-6) clinical outcomes on the 30th day. Results: In this study, the average age of the sample was 61.37 years. The largest population was in the 45-59 mL/min/1.73 m2 eGFR group (38,6%). The mean eGFR (p<0.001) for all samples, good, and bad outcome groups was respectively 59.90 ± 21.09, 79.79 ± 19.21, and 52.49 ± 16.57. In this study the poor outcome group had a lower mean eGFR than the good outcome group (52.49 mL/min/1.73 m2 vs 79.79 mL/min/1.73 m2), with a cut-off value of 62 mL/min/1.73 m2 (sensitivity 80.39%, specificity 84.21%) tended to have worse clinical outcomes. Conclusion: Based on the results of this study, eGFR has a relationship with clinical outcomes (p<0.001) and can objectively predict clinical outcomes on the 30th day of acute ischemic stroke.
High Density Lipoprotein (HDL) Level and Blood Urea Nitrogen (BUN)/Creatinin Ratio Relationship with One-Month Outcome in Acute Ischemic Stroke Patients Habib Djarkoni, Ilham; Iqbal Basri, Muhammad; Akbar, Muhammad; Hamid, Firdaus; Kurnia Bintang, Andi; Tamasse, Jumraini
Journal of Society Medicine Vol. 2 No. 12 (2023): December
Publisher : CoinReads Media Prima

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47353/jsocmed.v2i12.112

Abstract

Introduction: Stroke has caused around 15.5% of all deaths. Evaluation of factors that worsen clinical outcomes is necessary to avoid complications such as renal dysfunction and secondary dyslipidaemia. This study aims to determine the relationship between increasing serum HDL levels and blood urea nitrogen–serum creatinine ratio (BUN/Cr) on clinical outcomes of acute ischemic stroke. Method: Prospective cohort study was used with subjects being first-onset acute ischemic stroke patients. Demographic, clinical data, and assessment of BUN/Cr and HDL ratios were collected. Subjects were divided into good clinical outcome (mRS 0-2) and poor clinical outcome (mRS 3-6) groups, and then analysed using multiple linear regression multivariate analysis with confidence interval of 95%. Results: 60 participants met the inclusion criteria. There was a significant relationship between serum BCR levels and poor clinical outcomes (p <0.001) relationship between serum HDL levels and poor clinical outcomes also shown significances (p <0.001) Mean BCR in good and poor clinical outcomes of acute ischemic stroke were (17.08±30.13) and (29.35±67.30) respectively. Mean HDL in good and poor clinical outcomes were (39± 62) and (41 ± 92) respectively.  A multiple linear regression analysis showed a positive correlation (p <0.001) between increasing Serum HDL levels and Bun/Cr ratio simultaneously to poor clinical outcomes in acute ischemic stroke patients. The Cut-off point was 20.9 for BUN to creatinine ratio and 46 mg/dL at serum HDL. Both of BUN/Cr ratio and HDL were shown high specificity and could be used as predictors of clinical outcome in acute ischemic stroke patients. Conclusion: Increased BUN/Cr ratio and increased serum HDL levels were associated with clinical outcomes in patients with acute ischemic stroke.

Page 1 of 1 | Total Record : 5

 1 

Filter by Year

2023 2023


Reset
Filter By Issues
All Issue Vol. 4 No. 11 (2025): November Vol. 4 No. 10 (2025): October Vol. 4 No. 9 (2025): September Vol. 4 No. 8 (2025): August Vol. 4 No. 7 (2025): July Vol. 4 No. 6 (2025): June Vol. 4 No. 5 (2025): May Vol. 4 No. 4 (2025): April Vol. 4 No. 3 (2025): March Vol. 4 No. 2 (2025): February Vol. 4 No. 1 (2025): January Vol. 3 No. 12 (2024): December Vol. 3 No. 11 (2024): November Vol. 3 No. 10 (2024): Oktober Vol. 3 No. 9 (2024): September Vol. 3 No. 8 (2024): August Vol. 3 No. 7 (2024): July Vol. 3 No. 6 (2024): June Vol. 3 No. 5 (2024): May Vol. 3 No. 4 (2024): April Vol. 3 No. 3 (2024): March Vol. 3 No. 2 (2024): February Vol. 3 No. 1 (2024): January Vol. 2 No. 12 (2023): December Vol. 2 No. 11 (2023): November Vol. 2 No. 10 (2023): October Vol. 2 No. 9 (2023): September Vol. 2 No. 8 (2023): August Vol. 2 No. 7 (2023): July Vol. 2 No. 6 (2023): June Vol. 2 No. 5 (2023): May Vol. 2 No. 4 (2023): April Vol. 2 No. 3 (2023): March Vol. 2 No. 2 (2023): February Vol. 2 No. 1 (2023): January Vol. 1 No. 3 (2022): December Vol. 1 No. 2 (2022): November Vol. 1 No. 1 (2022): October More Issue